Artificial Intelligence in Drug Delivery Systems for Diagnosis and Treatment of Cancer
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 247
Special Issue Editors
Interests: biomedical engineering; bioinformatics; internet of medical things; artificial intelligence; pattern recognition; signal data science; metaverse
Interests: computer networking and security; software-defined networking; blockchain technology; artificial intelligence; machine learning; Internet of Things
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Artificial intelligence gives researchers and practitioners a new way of assessing cancer diagnosis and treatment. It enables the cancer diagnosis to be more predictive with better patient outcomes in order to be able to gain awareness of which treatments might work best for which persons. For most drugs to be active for cancer treatment, they must only target the affected cancer cells and penetrate the cells for drug delivery. Scientists have sought to develop tiny nanoparticles that can be loaded with drugs. Modified nanoparticles can become attached to cancer cells and carried inside. To ensure that the nanoparticles only attack the diseased cells, they need to be engineered to only point to the targeted cells without affecting the healthy cells. Upon reaching the digestive system of the cells, the nanoparticles are degraded once the drug is released into the cell. As a researcher, the magic wand of artificial-intelligence-aided solutions can be taken up to enable the intelligent categorization of affected cells so that the drugs can be delivered to the corresponding cells. Such intelligent means of drug delivery represent the best alternative to conventional chemotherapy. With proper awareness, the incorporation of artificial intelligence technology in drug delivery systems will be the best fit for the diagnosis and treatment of cancer. However, with the awareness and incorporation of novel artificial intelligence solutions for drug delivery still in its infancy, it is essential to support the complete eradication of cancer by predicting and treating them at much earlier stages.
There are still many challenges in improving the accuracy, efficiency, and usability of AI models for cancer treatment driving the drug delivery systems, and problems related to designing, developing, and deploying new reliable and ethical drug delivery mechanisms. Thus, this Special Issue focuses on current AI-enabled solutions for cancer drug delivery and presents the latest research advances in this particular field.
Prof. Dr. Victor Hugo C. De Albuquerque
Dr. Mohamed Rahouti
Dr. Senthil Kumar Jagatheesaperumal
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- artificial intelligence
- cancer treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
